Protocol for a mobile laboratory study of co-administration of cannabis concentrates with a standard alcohol dose in humans.
Hollis C Karoly, Mark A. Prince, Noah N Emery, Emma E Smith, Cianna J Piercey, Bradley T Conner
PLoS One 2022 DOI: 10.1371/journal.pone.0277123 (opens in new tab)
The journal has published a correction to this paper. Read the correction (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Clinical protocol Peer reviewed |
|---|---|
| Population | Community participants who regularly use alcohol and cannabis |
| Interventions | Legal-market cannabis concentrates Alcohol |
| Dose | 0.8 g/kg alcohol |
| Topics | Cannabis |
| Key points | The authors propose an experimental mobile-laboratory study to test how cannabinoid content (including high-potency concentrates) and order of use (cannabis before alcohol vs. alcohol before cannabis) affect acute intoxication when cannabis concentrates are co-administered with a moderate alcohol dose (0.8 g/kg). They argue this addresses gaps in conflicting co-use evidence and may inform harm-reduction recommendations. |
Abstract
Cannabis is commonly used among people who drink alcohol, yet evidence on acute effects of co-use is conflicting. Two important variables that may influence the effects of cannabis and alcohol are cannabinoid content (i.e., the ratio of cannabidiol [CBD] and 9-tetrahydrocannabinol [THC]) as well as the order of use (i.e., cannabis before alcohol vs. alcohol before cannabis). Research is mixed regarding the acute imapct of cannabis on alcohol consumption and intoxication, with some studies suggesting additive effects of alcohol and cannabis, and others demonstrating negligible effects of combining these substances. Further complicating this, high-THC-content cannabis concentrates are increasingly popular on the legal-market, but to our knowledge, no studies have explored concentrate and alcohol co-use. In addition to cannabinoid content, order of use may influence intoxication and other acute effects, but is also understudied. Co-use studies typically administer a fixed dose of alcohol before cannabis, and there is a lack of data on the acute effects of cannabis before alcohol. Thus, there is a need for experimental co-use studies exploring the impact of cannabinoid content (particularly of highly potent cannabis concentrates) and order effects on intoxication. This study uses a federally-compliant mobile laboratory procedure to explore the effects of co-administration of legal-market cannabis concentrates with a moderate alcohol dose (.8g/kg) in a sample of community participants who regularly use alcohol and cannabis. The study will also explore alcohol and cannabis order effects (cannabis before alcohol vs. alcohol before cannabis). Outcomes are objective intoxication (measured using blood cannabinoid level, heart rate, psychomotor performance and breath alcohol level [BrAC]) and subjective intoxication (assessed via self-report measures). Overall, this study may influence harm-reduction recommendations for individuals who drink alcohol and use cannabis.
Citations in the library
Cites 6
- Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users Psychopharmacology October 30, 2010
- A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment Psychopharmacology October 27, 2021
- Acute effects of high-potency cannabis flower and cannabis concentrates on everyday life memory and decision making. Scientific Reports July 2, 2021
- Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers. Pharmacology, Biochemistry, and Behavior November 24, 2010
- Biomarkers for the effects of cannabis and THC in healthy volunteers. British Journal of Clinical Pharmacology January 2009
and 1 more in the library